As of 2024-12-15, the Fair Value of Dechra Pharmaceuticals PLC (DPH.L) is -122.53 GBP. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 3,866.00 GBP, the upside of Dechra Pharmaceuticals PLC is -103.17%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-06-30 | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 5Y Avg | |
| Net income | 30.90 | 33.90 | 55.50 | 58.20 | -27.90 | 30.12 |
| YoY growth | -14.40% | 9.71% | 63.72% | 4.86% | -147.94% | -16.81% |
| Market Cap (mil) | 4,401.33 |
| P/E | |
| Forward P/E |
| EPS | -24.51 |
| Avg earnings growth rate | -16.81% |
| TTM earnings | -27.90 |